Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Y Maeda

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Chest|November 1, 1993
Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertensionA A Lopes, N Y Maeda, V D Aiello, et al.
Thrombosis Research|October 1, 1987
Human plasma kallikrein: effect on the induced platelet aggregationC M Cassaro, M U Sampaio, N Y Maeda, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
The role of bradykinin on the effect of plasma kallikrein on platelet aggregationN Y Maeda, C M Cassaro, M U Sampaio, et al.
Angiology|September 1, 1993
Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertensionA A Lopes, N Y Maeda, A Almeida, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|September 18, 2008
Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled studyA C Barreto, N Y Maeda, R P S Soares, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|November 10, 2011
Plasma von Willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart diseaseA A Lopes, A C Barreto, N Y Maeda, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Chest|November 1, 1993
Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertensionA A Lopes, N Y Maeda, V D Aiello, et al.
Thrombosis Research|October 1, 1987
Human plasma kallikrein: effect on the induced platelet aggregationC M Cassaro, M U Sampaio, N Y Maeda, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
The role of bradykinin on the effect of plasma kallikrein on platelet aggregationN Y Maeda, C M Cassaro, M U Sampaio, et al.
Angiology|September 1, 1993
Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertensionA A Lopes, N Y Maeda, A Almeida, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|September 18, 2008
Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled studyA C Barreto, N Y Maeda, R P S Soares, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|November 10, 2011
Plasma von Willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart diseaseA A Lopes, A C Barreto, N Y Maeda, et al.
Pageof 3